Hydroxycloroquine in COVID-19 Trial Restarted in UK

June 30, 2020 The British Medicines and Healthcare Products Regulatory Agency has approved the restart of a global trial that will explore whether the drugs hydroxychloroquine and chloroquine are able to prevent coronavirus infections. Led by Oxford University’s Mahidol Oxford Tropical Medicine Research Unit, the randomized, placebo-controlled trial will enroll around 40,000 healthcare workers and other at-risk workers […] Read More